<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00816127</url>
  </required_header>
  <id_info>
    <org_study_id>02-0727</org_study_id>
    <nct_id>NCT00816127</nct_id>
  </id_info>
  <brief_title>Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction</brief_title>
  <official_title>Intranasal DDAVP in Preventing Bleeding During Dental Extraction in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate how effective and cost saving
      1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) is as opposed to the transfusion of
      blood products in preventing bleeding after teeth extraction in persons with severe liver
      disease being evaluated for liver transplant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Liver cirrhosis is associated with dysregulation of the coagulation system resulting in an
      increased bleeding tendency in cirrhotic patients. The treatment approach to offset these
      abnormalities may involve transfusion with fresh frozen plasma (FFP) and platelets. Fluid
      overload may become a concern as the large amount of FFP (10-20mls/kg or &gt;1,500ml) required
      to achieve the hemostatic effect could be contraindicated in some patients. Furthermore,
      repeated platelet transfusion induces alloimmunization and refractoriness to new transfusion,
      which is an important issue in patients on the waiting list for liver transplantation in
      which HLA-matched and cross-matched platelets may be required. Non-transfusional drugs that
      help to stop bleeding have been used in patients with congenital bleeding disorders.
      1-deamino-8-D-arginine vasopressin (DDAVP, Desmopressin), a synthetic analogue of the
      antidiuretic hormone, L-arginine, has been used as a non-transfusional form of replacement
      therapy in a variety of congenital and acquired bleeding disorders. Through unknown
      mechanisms, DDAVP shortens the prolonged bleeding times of cirrhotic patients despite the
      high plasma concentrations of Factor VIII and von Willebrand factor sound in chronic liver
      disease, indicating that it might be useful as a prophylactic treatment in cirrhotic patients
      undergoing minimally invasive procedures, i.e. dental extraction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Necessity of rescue blood transfusion in patients who received DDAVP or blood transfusion prior to dental extraction.</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Coagulopathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DDAVP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desmopressin</intervention_name>
    <description>intranasal desmopressin (300Î¼g)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood transfusion</intervention_name>
    <description>fresh frozen plasma 10ml/kg and/or 1 unit of single donor platelets</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients with biopsy-proven liver cirrhosis or clinical/radiological evidence of
             cirrhosis, requiring dental extraction

          -  platelet count of 30,000-50,000/microL and/or INR 2.0-3.0

        Exclusion Criteria:

          -  the presence of other bleeding disorders besides cirrhosis such as renal dysfunction
             (creatinine &gt; 2.0) or HIV

          -  receipt of blood transfusion within 2 weeks prior to study

          -  recent acute decompensation of liver cirrhosis

          -  malignancy excluding hepatocellular carcinoma in the absence of portal vein thrombosis

          -  treatment with anti-platelet medications (aspirin, non-steroidal anti-inflammatory
             drugs or clopidogrel) within ten days prior to the extraction

          -  documented allergy to DDAVP.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas D. Schiano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis. 2002 Feb;22(1):83-96. Review.</citation>
    <PMID>11928081</PMID>
  </reference>
  <reference>
    <citation>Kobrinsky NL, Israels ED, Gerrard JM, Cheang MS, Watson CM, Bishop AJ, Schroeder ML. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet. 1984 May 26;1(8387):1145-8.</citation>
    <PMID>6144876</PMID>
  </reference>
  <reference>
    <citation>de la Fuente B, Kasper CK, Rickles FR, Hoyer LW. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med. 1985 Jul;103(1):6-14.</citation>
    <PMID>3923887</PMID>
  </reference>
  <reference>
    <citation>Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983 Jan 6;308(1):8-12.</citation>
    <PMID>6401193</PMID>
  </reference>
  <reference>
    <citation>Saulnier J, Marey A, Horellou MH, Goudemand J, Lepoutre F, Donazzan M, Gazengel C, Torchet M, Letang C, Schuhmann C, et al. Evaluation of desmopressin for dental extractions in patients with hemostatic disorders. Oral Surg Oral Med Oral Pathol. 1994 Jan;77(1):6-12.</citation>
    <PMID>8108099</PMID>
  </reference>
  <reference>
    <citation>Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977 Apr 23;1(8017):869-72.</citation>
    <PMID>67283</PMID>
  </reference>
  <reference>
    <citation>Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood. 1997 Oct 1;90(7):2515-21. Review.</citation>
    <PMID>9326215</PMID>
  </reference>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2008</study_first_submitted>
  <study_first_submitted_qc>December 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2008</study_first_posted>
  <last_update_submitted>December 31, 2008</last_update_submitted>
  <last_update_submitted_qc>December 31, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Thomas D. Schiano, M.D</name_title>
    <organization>Mount Sinai School of Medicine</organization>
  </responsible_party>
  <keyword>liver cirrhosis</keyword>
  <keyword>coagulopathy</keyword>
  <keyword>desmopressin</keyword>
  <keyword>blood transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deamino Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

